Liver resection of colorectal metastases in elderly patients
β Scribed by Professor R. Adam; A. Frilling; D. Elias; C. Laurent; E. Ramos; L. Capussotti; G. J. Poston; D. A. Wicherts; R. J. de Haas
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 156 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0007-1323
- DOI
- 10.1002/bjs.6889
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background
This study evaluated the outcome of liver surgery for colorectal metastases (CLM) in patients over 70 years old in a large international multicentre cohort.
Methods
Among 7764 patients who had resection of CLM, 999 (12Β·9 per cent) were aged 70β75 years, 468 (6Β·0 per cent) were aged 75β80 years and 157 (2Β·0 per cent) were at least 80 years old. Elderly patients were compared with the younger population.
Results
Multinodular and bilateral metastases were less common in elderly than in younger patients (P < 0Β·001). Preoperative chemotherapy was used less frequently and more limited surgery was performed (P < 0Β·001). Sixty-day postoperative mortality and morbidity rates were 3Β·8 and 32Β·3 per cent respectively, compared with 1Β·6 and 28Β·7 per cent in younger patients (both P < 0Β·001). Three-year overall survival was 57Β·1 per cent in elderly and 60Β·2 per cent in younger patients (P < 0Β·001), and was similar among patients aged 70β75, 75β80 or at least 80 years (57Β·8, 55Β·3 and 54Β·1 per cent respectively; P = 0Β·160). Independent predictors of survival were more than three metastases, bilateral metastases, concomitant extrahepatic disease and no postoperative chemotherapy.
Conclusion
Liver resection for CLM in elderly patients can achieve a reasonable 3-year survival rate, with an acceptable morbidity rate. There should be no upper age limit but risk factors may help predict potential benefit.
π SIMILAR VOLUMES
Abstract A 6 12 year experience in the management of hepatic colorectal metastases in a specialist unit is reviewed. During the period studied, 48 patients were referred of whom only 24 actually came to resection. There were two in-hospital deaths, at 20 and 60 days, and six patients had non-fatal c
The data used in this article were accrued during the authors' appointment at the Memorial Sloan-Kettering Cancer Center (MSKCC), but the opinions expressed herein are their own and do not necessarily reflect the current treatment policy of MSKCC.